BBA
COLL icon

Baader Bank Aktiengesellschaft’s Collegium Pharmaceutical COLL Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,004
Closed -$371K – 449
2025
Q4 		$371K Buy
+8,004
New +$335K 0.03% 345
2024
Q4 		– Sell
-6,500
Closed -$251K – 404
2024
Q3 		$251K Buy
+6,500
New +$232K 0.01% 326

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Baader Bank Aktiengesellschaft's COLL Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft sold out of Collegium Pharmaceutical (COLL) in Q1 2026, closing a stake of 8,004 shares — an estimated $371K sold.

Baader Bank Aktiengesellschaft first reported a position in COLL in Q3 2024 and held it in 2 quarters. The position peaked at $371K in Q4 2025. 267 funds tracked by Wall St. Rank hold COLL as of Q1 2026.

  • Baader Bank Aktiengesellschaft reported no remaining Collegium Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 8,004 Collegium Pharmaceutical shares in Q1 2026, an estimated $371K.
  • Baader Bank Aktiengesellschaft first reported a position in Collegium Pharmaceutical in Q3 2024 and held it in 2 quarters.
  • Baader Bank Aktiengesellschaft's Collegium Pharmaceutical position peaked at $371K in Q4 2025.
  • 267 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.